{
  "ticker": "ZLAB",
  "company_name": "Zai Lab Limited",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03551171",
      "title": "The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Ovarian Cancer",
      "start_date": "2017-12-19",
      "completion_date": "2018-07-10",
      "enrollment": 0,
      "sponsor": "Zai Lab (Shanghai) Co., Ltd."
    },
    {
      "nct_id": "NCT04178460",
      "title": "A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Gastric Cancer, Triple Negative Breast Cancer, Biliary Tract Carcinoma, Endometrial Carcinoma",
      "start_date": "2020-02-03",
      "completion_date": "2022-03-02",
      "enrollment": 0,
      "sponsor": "Zai Lab (Shanghai) Co., Ltd."
    },
    {
      "nct_id": "NCT07235384",
      "title": "A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Atopic Dermatitis (AD)",
      "start_date": "2025-12-01",
      "completion_date": "2027-12-28",
      "enrollment": 0,
      "sponsor": "Zai Lab (Shanghai) Co., Ltd."
    },
    {
      "nct_id": "NCT03694522",
      "title": "A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Gastric Cancer",
      "start_date": "2018-09-14",
      "completion_date": "2022-05-13",
      "enrollment": 0,
      "sponsor": "Five Prime Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04212221",
      "title": "MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Hepatocellular Carcinoma (HCC)",
      "start_date": "2020-04-20",
      "completion_date": "2022-04-27",
      "enrollment": 0,
      "sponsor": "Zai Lab (Shanghai) Co., Ltd."
    },
    {
      "nct_id": "NCT05859464",
      "title": "A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Malignant Solid Tumor",
      "start_date": "2023-07-24",
      "completion_date": "2025-08-28",
      "enrollment": 0,
      "sponsor": "Zai Lab (Hong Kong), Ltd."
    },
    {
      "nct_id": "NCT07218146",
      "title": "A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Small-cell Lung Cancer",
      "start_date": "2025-11-30",
      "completion_date": "2028-11-30",
      "enrollment": 0,
      "sponsor": "Zai Lab (Shanghai) Co., Ltd."
    },
    {
      "nct_id": "NCT04082364",
      "title": "Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer",
      "start_date": "2019-09-30",
      "completion_date": "2025-03-25",
      "enrollment": 0,
      "sponsor": "MacroGenics"
    },
    {
      "nct_id": "NCT03516084",
      "title": "A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Extensive-stage Small Cell Lung Cancer",
      "start_date": "2018-08-20",
      "completion_date": "2020-03-20",
      "enrollment": 0,
      "sponsor": "Zai Lab (Shanghai) Co., Ltd."
    },
    {
      "nct_id": "NCT05263986",
      "title": "The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors",
      "status": "UNKNOWN",
      "phase": "PHASE1",
      "condition": "Advanced or Metastatic Solid Tumor",
      "start_date": "2022-05-30",
      "completion_date": "2023-10-31",
      "enrollment": 0,
      "sponsor": "Zai Lab (Shanghai) Co., Ltd."
    }
  ],
  "summary": {
    "total_trials": 42,
    "by_phase": {
      "PHASE1": 14,
      "PHASE2": 14,
      "PHASE1, PHASE2": 3,
      "PHASE3": 9,
      "PHASE2, PHASE3": 1,
      "NA": 1
    },
    "by_status": {
      "COMPLETED": 17,
      "TERMINATED": 6,
      "RECRUITING": 9,
      "UNKNOWN": 7,
      "ACTIVE_NOT_RECRUITING": 2,
      "NOT_YET_RECRUITING": 1
    },
    "active_trials": 11,
    "completed_trials": 17,
    "conditions": [
      "Advanced Cancer",
      "Advanced Hepatocellular Carcinoma (HCC)",
      "Advanced Solid Tumor",
      "Advanced or Metastatic Solid Tumor",
      "Atopic Dermatitis (AD)",
      "Breast Cancer Metastatic",
      "Carcinoma, Non-Small-Cell Lung",
      "Chronic Obstructive Pulmonary Disease, Asthma, Idiopathic Pulmonary Fibrosis",
      "Community-acquired Bacterial Pneumonia",
      "Eczema",
      "Endometrial Carcinoma, Serous Carcinoma",
      "Epithelial Ovarian Cancer",
      "Extensive-stage Small Cell Lung Cancer",
      "Gastric Cancer",
      "Gastric Cancer, GastroEsophageal Cancer",
      "Gastric Cancer, Gastroesophageal Junction Adenocarcinoma",
      "Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer",
      "Gastric Cancer, Triple Negative Breast Cancer, Biliary Tract Carcinoma, Endometrial Carcinoma",
      "Gastrointestinal Stromal Tumor(GIST)",
      "Gastrointestinal Stromal Tumors",
      "HER2 Positive Metastatic Breast Cancer",
      "Healthy Volunteer",
      "Hepatocellular Carcinoma (HCC)",
      "Locally Advanced Solid Tumors, Metastatic Solid Tumors",
      "Lupus Nephritis",
      "Malignant Solid Tumor",
      "Membranous Nephropathy",
      "Ovarian Cancer",
      "Plaque Psoriasis",
      "Platinum-resistant Recurrent Clear Cell Ovarian Cancer",
      "Platinum-sensitive Relapsed Ovarian Cancer",
      "SCLC",
      "Schizophrenia",
      "Small-cell Lung Cancer",
      "Solid Malignancies",
      "Solid Tumors",
      "Solid Tumors, Sarcomas",
      "Thyroid Eye Disease (TED)",
      "Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:23:04.881048",
    "search_query": "Zai Lab Limited",
    "url": "https://clinicaltrials.gov/search?term=Zai+Lab+Limited"
  }
}